Financial Hearings Digital R&D Day
Financial Hearings Financial Hearings host a Digital R&D Day. Explore the key four metrics of Asarina Pharma’s Phase IIb trial with our CEO, CSO, COO,… Read More »Financial Hearings Digital R&D Day
Asarina Pharma
EFN
Bolaget som prickat in hälsovårdstrenderna, EFN. Handelsbanken hälsovård expert Astrid Samuelsson: “Asarina har ett väldigt intressant år framför sig, med data från flera studier som… Read More »EFN
OMNI EKONOMI
Asarina Pharma: DNB höjer riktkursen till 44 KR (37) (DNB increases target share value to 44 SEK) Swedish investor site on increased valuation of Asarina… Read More »OMNI EKONOMI
UR PLAY
PMDS: Förekomst, symptom, uttryck och behandling (PMDD: Prevention, symptoms, prevalence and treatment) CSO Torbjörn Bäckström, on Swedish educational TV channel UR Play, lectures on PMDD… Read More »UR PLAY
EXPRESSEN
Svenska forskare: Medicin finns snart mot svår PMDS (Swedish researchers: Treatment soon available for PMDD) CSO Prof Torbjörn Bäckström and COO Karin Ekberg interviewed by… Read More »EXPRESSEN
BBC WOMAN’S HOUR
Premenstrual Dysphoric Disorder (PMDD) UK’s premier women’s issue radio programme covers PMDD and Phase IIb trial for new treatment.
SVT NYHETER
Många lider i tysthet av svår PMS: ”Ett allvarligt handikapp” (Many suffer in silence from extreme PMS) CSO Prof Torbjörn Bäckström interviewed by Sweden’s largest… Read More »SVT NYHETER
BAAAM
Därför måste vi prata mer om PMS och PMDS (Why we need to talk more about PMS & PMDD) Swedish mobile news and lifestyle site… Read More »BAAAM
SvD NÄRINGSLIV
Asarina Pharma: Mycket forskning för pengarna (Asarina Pharma: A lot of research for your money) Swedish investor paper’s positive report on Asarina Pharma.
DAGENS INDUSTRI
Bioteknikbolaget Asarina Pharma tar sikte på USA (Biotech company Asarina Pharma targets US) Sweden’s largest business news channel interviews CEO Peter Nordkild.